MedPath

tility of contrast-enhanced intraoperative ultrasound using Sonazoid in patients undergoing surgery for liver metastasis from colorectal carcinoma - comparison with Gd-EOB-DTPA-MRI, contrast enhanced MDCT, and extracorporeal ultrasound

Not Applicable
Conditions
iver metastasis from colorectal carcinoma
Registration Number
JPRN-UMIN000005537
Lead Sponsor
Cancer institute hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

* History of allergy against Sonazoid or an egg * Contrast-enhanced MDCT or Gd-EOB-DTPA-MRI is impossible based on history of allergy or renal dysfunction * 10 or more liver metastases * Arterio-venous shunt in heart or lung * Severe heart disease * Severe pulmonary disease * Pregnant patients * Nursing mothers * Attending physician or the operator consider the study hazardous

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
*Frequency that contrast-enhanced intraoperative ultrasound alone finds new liver metastases that have not been detected by preoperative imaging studies or intraoperative ultrasound
Secondary Outcome Measures
NameTimeMethod
*Diagnostic abilities for liver metastasis of contrast-enhanced intraoperative ultrasound, Gd-EOB-DTPA-MRI, contrast-enhanced MDCT, extracorporeal contrast-enhanced ultrasoud and intraoperative ultrasoud *Diagnostic ability of contrast-enhanced intraoperative ultrasound among new focal liver lesions that are found by intraoprative ultrasound *Frequency that the planned surgical precedure is altered through contrast-enhanced intraoperative ultrasound
© Copyright 2025. All Rights Reserved by MedPath